— Know what they know.
Not Investment Advice
Also trades as: 0K16.L (LSE) · $vol 0M

EOLS NASDAQ

Evolus, Inc.
1W: -2.0% 1M: +24.3% 3M: +47.6% YTD: -4.0% 1Y: -35.2% 3Y: -33.6% 5Y: -28.8%
$6.09
-0.36 (-5.58%)
 
Weekly Expected Move ±9.3%
$5 $6 $6 $7 $8
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 63 · $401.1M mcap · 50M float · 2.26% daily turnover · Short 28% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.8 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -29.2%
Cost Advantage
59
Intangibles
43
Switching Cost
81
Network Effect
78
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EOLS has a Narrow competitive edge (59.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. Negative ROIC of -29.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$16
Avg Target
$16
High
Based on 4 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$16.00
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-04 Mizuho Securities Uy Ear $19 $15 -4 +219.1% $4.70
2026-01-22 BTIG Initiated $13 +165.3% $4.90
2026-01-13 Stifel Nicolaus Annabel Samimy Initiated $17 +194.6% $5.77
2025-12-01 Mizuho Securities Vamil Divan $25 $19 -6 +178.6% $6.82
2024-10-03 H.C. Wainwright Douglas Tsao Initiated $27 +58.4% $17.05
2024-09-13 Barclays Balaji Prasad $16 $20 +4 +21.5% $16.46
2024-09-13 Mizuho Securities Vamil Divan Initiated $25 +51.9% $16.46
2024-01-28 Barclays Balaji Prasad Initiated $16 +18.8% $13.47

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EOLS receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

27 Grade D
Profitability
19
Balance Sheet
38
Earnings Quality
58
Growth
74
Value
15
Momentum
69
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. EOLS scores highest in Growth (74/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.10
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
-2.37
Unlikely Manipulator
Ohlson O-Score
-3.67
Bankruptcy prob: 2.5%
Low Risk
Credit Rating
B-
Score: 20.0/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.84x
Accruals: -3.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EOLS scores -2.10, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EOLS scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. EOLS's score of -2.37 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EOLS's implied 2.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EOLS receives an estimated rating of B- (score: 20.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-9.14x
PEG
-0.36x
P/S
1.33x
P/B
-13.79x
P/FCF
-6.48x
P/OCF
EV/EBITDA
-26.30x
EV/Revenue
1.22x
EV/EBIT
-15.84x
EV/FCF
-8.93x
Earnings Yield
-16.21%
FCF Yield
-15.42%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. EOLS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.020
NI / EBT
×
Interest Burden
1.826
EBT / EBIT
×
EBIT Margin
-0.077
EBIT / Rev
×
Asset Turnover
1.317
Rev / Assets
×
Equity Multiplier
-26.071
Assets / Equity
=
ROE
493.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EOLS's ROE of 493.9% is driven by Asset Turnover (1.317), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.02 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.09
Median 1Y
$3.93
5th Pctile
$1.17
95th Pctile
$13.20
Ann. Volatility
74.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David Moatazedi
President and Chief Executive Officer
$775,000 $3,886,569 $6,412,214
Tatjana Mitchell Financial
ancial Officer
$154,224 $1,420,509 $3,163,272
Sandra Beaver Financial
ief Financial Officer
$231,904 $968,607 $1,699,898
Rui Avelar, M.D.
Chief Medical Officer and Head of Research and Development
$545,400 $645,756 $1,699,084
Tomoko Yamagishi-Dressler Marketing
ief Marketing Officer
$285,163 $484,317 $1,588,108

CEO Pay Ratio

10:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,412,214
Avg Employee Cost (SGA/emp): $661,036
Employees: 334

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
334
+0.6% YoY
Revenue / Employee
$889,749
Rev: $297,176,000
Profit / Employee
$-154,614
NI: $-51,641,000
SGA / Employee
$661,036
Avg labor cost proxy
R&D / Employee
$28,671
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -40.4% -42.9% -10.5% -15.9% -17.6% -17.8% -1.5% -1.4% -1.3% -1.3% 56.3% 54.8% 48.6% 50.6% 6.6% 7.4% 8.2% 7.7% 5.9% 4.9% 4.94%
ROA -58.4% -62.0% -20.1% -30.3% -33.7% -34.0% -34.2% -32.9% -30.5% -28.9% -33.6% -32.7% -29.0% -30.2% -23.9% -26.7% -29.4% -27.8% -22.5% -18.9% -18.94%
ROIC 2.4% 2.5% -3.4% -5.2% -5.6% -5.5% -1.3% -1.3% -1.1% -1.0% -90.4% -84.7% -71.1% -74.8% -56.0% -66.2% -70.2% -63.8% -37.6% -29.2% -29.21%
ROCE -1.9% -2.2% -31.8% -30.8% -32.8% -32.3% -43.8% -42.2% -39.9% -37.2% -32.1% -29.5% -23.6% -24.4% -17.7% -21.2% -23.2% -21.5% -20.8% -15.5% -15.48%
Gross Margin 56.7% 56.9% 54.3% 61.0% 57.4% 60.2% 69.4% 70.9% 70.2% 69.1% 63.6% 68.3% 70.3% 70.2% 63.8% 68.1% 65.3% 66.5% 65.7% 64.8% 64.75%
Operating Margin -58.6% -71.6% -52.0% -45.6% -57.4% -52.8% -24.4% -28.9% -30.6% -26.9% -14.2% -15.0% -11.5% -25.3% -2.9% -22.1% -14.7% -16.7% -0.3% -9.4% -9.38%
Net Margin -59.8% -72.8% -52.4% -51.6% -63.2% -59.8% -30.2% -35.5% -36.8% -33.8% -19.4% -22.1% -17.0% -31.4% -8.6% -27.6% -24.7% -22.8% 0.1% -14.6% -14.59%
EBITDA Margin -46.6% -62.9% -42.9% -39.0% -46.0% -46.5% -17.9% -25.3% -27.3% -23.3% -6.1% -11.5% -7.5% -21.3% 0.8% -18.4% -11.3% -13.8% 7.8% -5.1% -5.13%
FCF Margin -11.9% -31.3% -34.1% -52.6% -76.5% -62.4% -59.1% -45.1% -37.1% -24.9% -17.5% -11.7% -8.5% -10.4% -8.6% -10.5% -16.8% -19.7% -16.3% -13.7% -13.69%
OCF Margin -10.7% -31.1% -33.5% -52.1% -75.7% -61.0% -57.1% -43.0% -35.4% -23.6% -16.8% -10.9% -7.2% -8.9% -6.8% -8.4% -14.9% -17.6% -14.2% -12.1% -12.12%
ROA 3Y Avg snapshot only -25.05%
ROIC 3Y Avg snapshot only -52.62%
ROIC Economic snapshot only -18.12%
Cash ROA snapshot only -16.20%
Cash ROIC snapshot only -46.87%
CROIC snapshot only -52.94%
NOPAT Margin snapshot only -7.56%
Pretax Margin snapshot only -14.10%
R&D / Revenue snapshot only 3.18%
SGA / Revenue snapshot only 71.61%
SBC / Revenue snapshot only 3.19%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -4.93 -3.01 -7.73 -8.84 -8.28 -5.69 -5.68 -6.66 -6.23 -8.27 -9.77 -13.72 -12.79 -18.45 -13.88 -13.63 -9.59 -6.79 -8.30 -6.17 -9.142
P/S Ratio 8.45 4.90 3.63 5.15 4.91 3.24 2.84 3.05 2.45 2.82 2.98 3.75 2.87 4.12 2.63 2.78 2.14 1.39 1.44 0.89 1.329
P/B Ratio -8.87 -5.75 4.42 7.64 7.95 5.52 22.84 25.83 22.37 28.17 -29.14 -39.79 -32.89 -49.45 126.69 138.77 107.64 71.97 -18.55 -11.60 -13.793
P/FCF -70.88 -15.63 -10.65 -9.79 -6.42 -5.19 -4.81 -6.78 -6.62 -11.32 -17.02 -31.98 -33.78 -39.63 -30.65 -26.51 -12.74 -7.05 -8.85 -6.48 -6.483
P/OCF
EV/EBITDA -14.13 -7.77 -5.01 -9.71 -9.35 -6.25 -8.23 -9.73 -9.12 -12.46 -16.92 -24.90 -27.38 -38.07 -30.67 -26.99 -19.44 -15.03 -23.18 -26.30 -26.303
EV/Revenue 8.85 5.26 2.91 4.56 4.37 2.73 2.98 3.19 2.58 2.93 3.30 4.04 3.14 4.38 2.79 2.94 2.29 1.54 1.78 1.22 1.223
EV/EBIT -12.20 -6.97 -4.56 -9.00 -8.83 -5.90 -7.70 -8.99 -8.28 -11.09 -14.78 -21.38 -22.44 -31.66 -24.76 -22.46 -16.22 -12.06 -16.95 -15.84 -15.835
EV/FCF -74.25 -16.77 -8.54 -8.67 -5.72 -4.37 -5.04 -7.07 -6.95 -11.76 -18.81 -34.45 -36.94 -42.09 -32.54 -28.00 -13.66 -7.82 -10.94 -8.93 -8.931
Earnings Yield -20.3% -33.2% -12.9% -11.3% -12.1% -17.6% -17.6% -15.0% -16.0% -12.1% -10.2% -7.3% -7.8% -5.4% -7.2% -7.3% -10.4% -14.7% -12.0% -16.2% -16.21%
FCF Yield -1.4% -6.4% -9.4% -10.2% -15.6% -19.3% -20.8% -14.8% -15.1% -8.8% -5.9% -3.1% -3.0% -2.5% -3.3% -3.8% -7.8% -14.2% -11.3% -15.4% -15.42%
EV/Gross Profit snapshot only 1.866
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 0.71 0.71 3.10 3.10 3.10 3.10 2.17 2.17 2.17 2.17 2.33 2.33 2.33 2.33 2.40 2.40 2.40 2.40 1.90 1.90 1.898
Quick Ratio 0.69 0.69 3.07 3.07 3.07 3.07 1.76 1.76 1.76 1.76 2.10 2.10 2.10 2.10 2.21 2.21 2.21 2.21 1.54 1.54 1.540
Debt/Equity -1.90 -1.90 0.91 0.91 0.91 0.91 4.02 4.02 4.02 4.02 -6.12 -6.12 -6.12 -6.12 23.54 23.54 23.54 23.54 -6.71 -6.71 -6.708
Net Debt/Equity -0.87 -0.87 -0.87 -0.87 1.11 1.11 1.11 1.11 7.79 7.79 7.79 7.79
Debt/Assets 0.66 0.66 0.29 0.29 0.29 0.29 0.42 0.42 0.42 0.42 0.67 0.67 0.67 0.67 0.56 0.56 0.56 0.56 0.69 0.69 0.686
Debt/EBITDA -2.88 -2.39 -1.29 -1.31 -1.21 -1.23 -1.38 -1.45 -1.56 -1.71 -3.21 -3.55 -4.66 -4.43 -5.37 -4.33 -3.96 -4.43 -6.78 -11.05 -11.046
Net Debt/EBITDA -0.64 -0.53 1.23 1.25 1.15 1.17 -0.38 -0.40 -0.43 -0.47 -1.62 -1.79 -2.34 -2.23 -1.78 -1.43 -1.31 -1.47 -4.43 -7.21 -7.210
Interest Coverage -8.51 -15.82 -45.57 -21.99 -14.33 -9.77 -6.33 -5.63 -4.79 -3.94 -3.26 -2.64 -1.92 -1.88 -1.60 -1.95 -1.88 -1.80 -1.59 -1.21 -1.211
Equity Multiplier -2.87 -2.87 3.14 3.14 3.14 3.14 9.62 9.62 9.62 9.62 -9.14 -9.14 -9.14 -9.14 42.12 42.12 42.12 42.12 -9.78 -9.78 -9.775
Cash Ratio snapshot only 0.715
Debt Service Coverage snapshot only -0.729
Cash to Debt snapshot only 0.347
FCF to Debt snapshot only -0.267
Defensive Interval snapshot only 174.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.34 0.38 0.43 0.52 0.57 0.60 0.68 0.72 0.77 0.85 1.10 1.20 1.29 1.35 1.26 1.31 1.32 1.36 1.30 1.32 1.317
Inventory Turnover 6.16 7.17 17.02 20.26 22.03 22.81 5.42 5.32 5.21 5.40 4.32 4.77 5.11 5.30 7.38 7.65 8.01 8.44 5.12 5.32 5.316
Receivables Turnover 7.53 8.42 8.19 9.97 10.88 11.47 8.01 8.43 9.09 9.96 7.63 8.29 8.96 9.37 6.81 7.04 7.11 7.31 5.81 5.90 5.896
Payables Turnover 3.90 4.54 5.54 6.60 7.18 7.43 7.44 7.30 7.15 7.41 9.77 10.78 11.56 11.98 12.66 13.11 13.74 14.46 6.14 6.38 6.380
DSO 48 43 45 37 34 32 46 43 40 37 48 44 41 39 54 52 51 50 63 62 61.9 days
DIO 59 51 21 18 17 16 67 69 70 68 84 77 71 69 49 48 46 43 71 69 68.7 days
DPO 93 80 66 55 51 49 49 50 51 49 37 34 32 30 29 28 27 25 59 57 57.2 days
Cash Conversion Cycle 14 14 0 -1 -1 -1 64 62 59 55 95 87 81 77 74 72 70 68 75 73 73.4 days
Operating Cycle snapshot only 130.6 days
Cash Velocity snapshot only 5.607
Capital Intensity snapshot only 0.748
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 50.4% 54.5% 76.3% 1.1% 72.9% 63.1% 49.1% 28.9% 27.3% 32.3% 36.0% 40.4% 40.7% 34.4% 31.8% 25.4% 17.1% 15.1% 11.6% 9.6% 9.56%
Net Income -59.5% -1.1% 71.3% 48.3% 40.2% 43.0% -59.0% -1.4% 15.5% 20.7% 17.1% 16.3% 19.8% 12.0% 18.3% 6.3% -16.5% -5.6% -2.4% 22.7% 22.74%
EPS -5.2% -27.9% 82.6% 61.9% 45.4% 44.2% -57.0% -0.1% 16.8% 21.8% 18.5% 19.6% 27.2% 20.5% 26.2% 13.5% -13.2% -3.0% -0.7% 24.5% 24.50%
FCF 89.5% 64.5% 44.1% -60.4% -10.1% -2.2% -1.6% -10.3% 38.3% 47.2% 59.7% 63.5% 67.8% 43.9% 35.6% -12.3% -1.3% -1.2% -1.1% -43.0% -42.98%
EBITDA 27.1% -17.5% -8.2% -8.3% -29.1% -5.1% 7.1% 10.2% 23.2% 28.6% 26.9% 30.4% 42.9% 34.3% 38.5% 15.8% -20.6% -2.7% 5.6% 53.2% 53.20%
Op. Income -53.8% -96.6% 72.3% 45.6% 41.6% 45.9% -47.1% 8.8% 24.7% 29.5% 24.6% 25.5% 30.5% 20.5% 30.1% 11.8% -11.6% 3.8% -8.0% 29.0% 29.02%
OCF Growth snapshot only -58.95%
Asset Growth snapshot only -2.88%
Equity Growth snapshot only -5.18%
Debt Growth snapshot only 19.25%
Shares Change snapshot only 2.34%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 2.9% 1.1% 62.0% 51.0% 49.1% 49.4% 52.9% 55.6% 45.8% 42.6% 38.8% 31.4% 28.0% 27.0% 26.0% 24.5% 24.49%
Revenue 5Y 1.5% 74.2% 50.1% 43.4% 40.4% 38.8% 39.4% 38.9% 38.94%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 2.6% 94.2% 53.9% 50.2% 52.3% 55.8% 60.8% 60.5% 51.3% 49.5% 47.7% 39.1% 34.5% 32.3% 28.6% 24.9% 24.87%
Gross Profit 5Y 1.5% 72.4% 48.0% 44.2% 41.6% 40.7% 42.9% 40.7% 40.68%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 11.2% 11.2% 14.4% 14.4% 14.4% 14.4% -9.5% -9.5% -9.5% -9.5% -3.3% -3.3% -3.3% -3.3% -3.3% -3.3% -3.3% -3.3% 8.3% 8.3% 8.27%
Assets 5Y 3.2% 3.2% 3.2% 1.9% 1.9% 1.9% 1.9% -0.7% -0.7% -0.7% -0.7% 1.6% 1.6% 1.56%
Equity 3Y -38.5% -38.5% -38.5% -38.5% -59.3% -59.3% -59.3% -59.3%
Book Value 3Y -49.7% -48.2% -48.3% -48.3% -61.0% -61.1% -61.2% -61.2%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.91 0.98 0.99 0.94 0.98 0.99 0.97 0.94 0.97 0.98 0.98 0.98 0.99 0.99 0.98 0.98 0.99 0.99 0.99 0.99 0.990
Earnings Stability 0.95 0.74 0.03 0.47 0.49 0.34 0.00 0.26 0.19 0.08 0.01 0.03 0.16 0.17 0.34 0.60 0.45 0.27 0.45 0.72 0.721
Margin Stability 0.92 0.90 0.86 0.93 0.91 0.90 0.88 0.94 0.93 0.91 0.92 0.93 0.91 0.90 0.90 0.93 0.93 0.93 0.94 0.96 0.961
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.81 0.84 0.83 0.50 0.99 0.94 0.92 0.93 0.93 0.92 0.95 0.93 0.97 0.93 0.98 0.99 0.91 0.909
Earnings Smoothness
ROE Trend
Gross Margin Trend -0.07 -0.08 -0.09 -0.07 -0.05 -0.02 0.05 0.06 0.09 0.11 0.09 0.06 0.05 0.04 0.03 0.02 -0.01 -0.03 -0.02 -0.02 -0.022
FCF Margin Trend 16.52 3.37 1.60 1.00 0.15 0.21 0.12 0.15 0.07 0.22 0.29 0.37 0.48 0.33 0.30 0.18 0.06 -0.02 -0.03 -0.03 -0.026
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.06 0.19 0.71 0.89 1.28 1.07 1.14 0.94 0.90 0.69 0.55 0.40 0.32 0.40 0.36 0.41 0.67 0.86 0.82 0.84 0.843
FCF/OCF 1.11 1.01 1.02 1.01 1.01 1.02 1.03 1.05 1.05 1.06 1.04 1.07 1.17 1.17 1.27 1.26 1.13 1.12 1.15 1.13 1.130
FCF/Net Income snapshot only 0.952
CapEx/Revenue 1.2% 0.3% 0.6% 0.5% 0.8% 1.4% 2.0% 2.0% 1.7% 1.3% 0.7% 0.8% 1.2% 1.5% 1.8% 2.1% 1.9% 2.1% 2.1% 1.6% 1.57%
CapEx/Depreciation snapshot only 0.511
Accruals Ratio -0.55 -0.50 -0.06 -0.03 0.09 0.02 0.05 -0.02 -0.03 -0.09 -0.15 -0.20 -0.20 -0.18 -0.15 -0.16 -0.10 -0.04 -0.04 -0.03 -0.030
Sloan Accruals snapshot only -0.131
Cash Flow Adequacy snapshot only -7.718
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -8.5% -15.2% -28.7% -16.6% -1.4% -0.0% 0.0% 0.0% -0.0% -0.0% -0.0% -5.7% -7.5% -5.0% -7.3% -0.5% -0.1% -0.1% -0.1% -0.2% -0.15%
Total Shareholder Return -8.5% -15.2% -28.7% -16.6% -1.4% -0.0% 0.0% 0.0% -0.0% -0.0% -0.0% -5.7% -7.5% -5.0% -7.3% -0.5% -0.1% -0.1% -0.1% -0.2% -0.15%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.020
Interest Burden (EBT/EBIT) 2.37 2.16 0.74 1.15 1.20 1.23 1.29 1.29 1.26 1.29 1.36 1.44 1.60 1.61 1.66 1.54 1.56 1.58 1.63 1.83 1.826
EBIT Margin -0.73 -0.75 -0.64 -0.51 -0.50 -0.46 -0.39 -0.35 -0.31 -0.26 -0.22 -0.19 -0.14 -0.14 -0.11 -0.13 -0.14 -0.13 -0.11 -0.08 -0.077
Asset Turnover 0.34 0.38 0.43 0.52 0.57 0.60 0.68 0.72 0.77 0.85 1.10 1.20 1.29 1.35 1.26 1.31 1.32 1.36 1.30 1.32 1.317
Equity Multiplier 69.17 69.17 52.32 52.32 52.32 52.32 4.34 4.34 4.34 4.34 -167.57 -167.57 -167.57 -167.57 -27.80 -27.80 -27.80 -27.80 -26.07 -26.07 -26.071
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.57 $-2.53 $-0.84 $-1.27 $-1.40 $-1.41 $-1.32 $-1.27 $-1.17 $-1.11 $-1.08 $-1.02 $-0.85 $-0.88 $-0.80 $-0.88 $-0.96 $-0.90 $-0.80 $-0.67 $-0.67
Book Value/Share $-1.43 $-1.33 $1.47 $1.47 $1.46 $1.46 $0.33 $0.33 $0.32 $0.32 $-0.36 $-0.35 $-0.33 $-0.33 $0.09 $0.09 $0.09 $0.09 $-0.36 $-0.35 $-0.44
Tangible Book/Share $-2.92 $-2.72 $0.18 $0.18 $0.18 $0.18 $-0.91 $-0.91 $-0.90 $-0.90 $-1.55 $-1.51 $-1.42 $-1.41 $-1.02 $-1.01 $-1.00 $-1.00 $-1.43 $-1.42 $-1.42
Revenue/Share $1.50 $1.56 $1.79 $2.18 $2.36 $2.49 $2.64 $2.77 $2.96 $3.24 $3.53 $3.74 $3.78 $3.93 $4.20 $4.32 $4.31 $4.42 $4.61 $4.63 $4.63
FCF/Share $-0.18 $-0.49 $-0.61 $-1.15 $-1.81 $-1.55 $-1.56 $-1.25 $-1.10 $-0.81 $-0.62 $-0.44 $-0.32 $-0.41 $-0.36 $-0.45 $-0.72 $-0.87 $-0.75 $-0.63 $-0.63
OCF/Share $-0.16 $-0.48 $-0.60 $-1.13 $-1.79 $-1.52 $-1.51 $-1.19 $-1.05 $-0.76 $-0.59 $-0.41 $-0.27 $-0.35 $-0.28 $-0.36 $-0.64 $-0.78 $-0.66 $-0.56 $-0.56
Cash/Share $2.10 $1.96 $2.63 $2.62 $2.61 $2.60 $0.96 $0.95 $0.95 $0.95 $1.10 $1.07 $1.00 $1.00 $1.37 $1.37 $1.35 $1.34 $0.83 $0.83 $0.76
EBITDA/Share $-0.94 $-1.05 $-1.04 $-1.02 $-1.10 $-1.08 $-0.96 $-0.91 $-0.84 $-0.76 $-0.69 $-0.61 $-0.43 $-0.45 $-0.38 $-0.47 $-0.51 $-0.45 $-0.35 $-0.22 $-0.22
Debt/Share $2.70 $2.51 $1.34 $1.34 $1.33 $1.33 $1.32 $1.32 $1.31 $1.31 $2.21 $2.15 $2.02 $2.00 $2.05 $2.04 $2.01 $2.01 $2.40 $2.38 $2.38
Net Debt/Share $0.60 $0.56 $-1.29 $-1.28 $-1.28 $-1.27 $0.36 $0.36 $0.36 $0.36 $1.11 $1.08 $1.02 $1.01 $0.68 $0.68 $0.67 $0.66 $1.57 $1.55 $1.55
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -2.097
Altman Z-Prime snapshot only -7.141
Piotroski F-Score 3 2 5 6 5 5 2 3 4 4 5 5 6 6 6 5 4 5 3 3 3
Beneish M-Score -3.70 -4.71 -2.13 -1.32 -1.68 -2.01 -1.87 -2.22 -2.30 -2.55 -2.78 -3.01 -3.06 -3.04 -2.67 -2.70 -2.38 -2.14 -2.48 -2.37 -2.368
Ohlson O-Score snapshot only -3.667
Net-Net WC snapshot only $-1.63
EVA snapshot only $-30608170.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 15.70 15.72 29.88 35.37 35.61 30.83 23.48 23.23 22.91 22.86 20.00 20.00 20.00 20.00 22.53 22.23 21.79 21.32 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only -2.230
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 11
Sector Credit Rank snapshot only 10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms